![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Detectable Resistance to Tenofovir Disoproxil Fumarate (TDF) in HBeAg+ and HBeAg- Patients With Chronic Hepatitis B (CHB) After Eight Years of Treatment
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Amoreena Corsa,1 Yang Liu,1 John Flaherty,1 Patrick Marcellin,2 Michael Miller,1 Kathryn M. Kitrinos1
1Gilead Sciences, Inc., Foster City, CA; 2Hopital Beaujon, University of Paris, Clichy, France
![AASLD1.gif](../images/010915/010915-11/AASLD1.gif)
![AASLD2.gif](../images/010915/010915-11/AASLD2.gif)
![AASLD3.gif](../images/010915/010915-11/AASLD3.gif)
![AASLD4.gif](../images/010915/010915-11/AASLD4.gif)
![AASLD5.gif](../images/010915/010915-11/AASLD5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|